WallStSmart
TPST

Tempest Therapeutics Inc

NASDAQ: TPST · HEALTHCARE · BIOTECHNOLOGY

$1.74
+2.96% today

Updated 2026-04-29

Market cap
$24.67M
P/E ratio
P/S ratio
EPS (TTM)
$-6.33
Dividend yield
52W range
$2 – $12
Volume
0.2M

Tempest Therapeutics Inc (TPST) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-91.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-5.2%
2026-03-30
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-30$-0.62+0.0%$1.73$1.64-5.2%
2025-11-05$-0.79-170.8%$9.12$9.54+4.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.62$-0.62+0.0%
2025-09-30$-0.29$-0.79-170.8%
2025-06-30$-0.28$-2.07-639.3%
2025-03-31$-3.29$-3.16+4.0%$486000.00
2024-12-31$-0.25$-0.31-26.5%$486000.00
2024-09-30$-0.36$-0.41-13.9%
2024-06-30$-0.40$-0.42-5.0%
2024-03-31$-0.37$-0.36+2.7%
2023-12-31$-0.39$-0.38+2.6%
2023-09-30$-0.57$-0.48+15.8%
2023-06-30$-0.52$-0.54-3.8%
2023-03-31$-0.64$-0.55+14.1%

Frequently asked questions

Has Tempest Therapeutics Inc beaten earnings estimates?
Tempest Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -91.7% over the last 4 quarters.
How does TPST stock react to earnings?
TPST stock has moved an average of -0.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.